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enzymes during infection. I am interested in elucidating the factors that influence stability of the capsid shell and capturing the
structural interactions between HIV capsid, host restriction factors, and small molecules using biochemical and structural biology
techniques. HIV capsid shell was broken down and purified into hexamer and pentamer units for in vitro study. Structural assays
were performed using X-ray crystallography and biochemical analysis was performed using pelleting assays. By understanding
capsid structure with factors that confer stability, treatments can be designed to target the protective HIV capsid before the critical
step of viral genome integration with host DNA.

INTRODUCTION

hexamer and pentamer contains an electropositive pore that
mediates binding with many small negatively charged

Human immunodeficiency virus 1 (HIV-1) affects

molecules. The charged pore, ringed by a one arginine residue

millions of people around the world. One particular strain,

per monomer, presents an environment that is known to interact

called HIV-1, infects immune cells such as CD4+ T cells and

with phosphate moieties of inositol hexaphosphate (IP62) and

macrophages1. If not treated properly, HIV-1 can develop into

deoxynucleoside triphosphate (dNTPs3) which promotes charge

acquired immunodeficiency syndrome (AIDS) which currently

stability and acts as a nucleotide fuel source for the HIV-1

has no cure. Due to its aggressive nature and high-replication

enzyme reverse transcriptase. Small molecule binding to capsid

rate, HIV-1 is able to circumvent innate host cellular defense

is a relatively recent discovery and is a field where capsid

mechanisms. In a mature HIV-1 virion, the viral genome and its

dynamics can be studied. The capsid must maintain a delicate

vital accessory proteins and enzymes are housed within a

balance by remaining stable enough to protect HIV genetic

conical lattice structure known as the capsid. The capsid is

material while also being able to break apart to allow cDNA to

composed of a protein shell of monomers called CA protein

integrate into the host genome. It is important to understand how

which polymerize to form ~200 hexamers and 12 pentamers per

CA hexamer/CA pentamer structure, and by extension that of

fullerene cone. The capsid facilitates infection by interacting

the entire capsid lattice, is affected by small molecule binding,

with multiple host cellular factors while simultaneously

which may result in stability changes or larger scale structural

protecting viral genetic material and thus serves as a therapeutic

alterations.

target before the critical step of genome integration. Each CA
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Using structural biology, which studies the molecular

protein 1 (PQBP1) and poly-E peptide were investigated with

structure and dynamics of biological macromolecules, complex

hexamer pores due to having similar charged properties as

protein interactions and functions can be studied in vitro.

FEZ1. Furthermore, IP6 was used as a binding agent to hexamer

Former studies using structure-based crystallography, which

and pentamer pores2. After purification and capsid assembly,

utilizes fired X-ray beams at a crystalline layer of protein(s) to

biochemical and structural studies were performed to continue

calculate the structure of a molecule from its diffraction pattern,

elucidating the molecular details of CA hexamer and CA

have not produced high resolution data. Currently, capsid is

pentamer. Using studies on the regulation and structural stability

difficult to visualize on a structural level due to inherent

of CA hexamer and CA pentamer presents opportunities to

shortfalls in CA hexamer structure determination. When solving

develop more rapid and affordable diagnostic tests and drugs

the structure of hexamers, electron density from each CA

against CA, one of the earliest protein biomarkers in HIV

monomer is averaged together due to 6-fold hexameric

infection8.

symmetry in order to increase the signal:noise ratio and gain a
higher resolution model. Since the data is symmetrically

EXPERIMENTAL PROCEDURE

averaged, anything bound to the hexamer also has its density
averaged out six-fold2, preempting any useful information of

Culture and Growth
HIV-1 CA (A14C/E45C; hexamers for tube assembly)

asymmetric binding modes of molecules other than CA. IP6, a
small molecule, is inherently asymmetric with binding that may

or

induce slight conformational changes in a hexamer that could

(L21C/N22C/W184A/M185A; soluble pentamers) was cloned

propagate throughout the lattice of the capsid to trigger larger

into pET11a using Nde1/BAMH1 restriction sites and

scale stability and structure changes. Previous work in Dr.

transformed into BL21(DE3) cells. Cells were grown at 37 oC

X

a a

and 200 rpm until OD600 ~0.6-0.8 and induced with 0.5 mM

nanobodies with cyclophilin A (CypA4), can break the six-fold

IPTG at 25oC for 12 hours. Cells were spun in centrifuge at 5000

symmetry, potentially allowing for us to visualize any small

RPM for 10 minutes and pellets were stored at -80oC.

ab

a c

a

b d

a

,

c a

(A14C/E45C/W184A/M185A;

soluble

hexamers)

or

molecules that may bind asymmetrically. By breaking the sixfold symmetry, we can gain insight into known small molecule
binding and potentially discover other small molecules/peptides
Our lab mimicked the in vitro native capsid through

Mini, EDTA-free protease inhibitor (Roche). Cells were lysed

established

with a microfluidizer at 15000 psi followed by centrifugation

Through the addition of disulfides, we can

for 35 minutes at 15000 RPM. Lysate volume was

crosslinking

mechanisms5.

Thawed cell pellets were resuspended in 50 mM Tris
pH8, 300 mM NaCL, 0.2 mM TCEP and a tablet of cOmplete

that may bind similarly or at other sites.
disulfide

CA Preparation

technology

using

effectively

proportionally combined with ammonium sulfate to achieve

recapitulating at least the face of the capsid that binding factors

25% total volume saturation at 4oC and stirred in cold room for

see. Previous studies have shown that small molecules, such as

2 hours. Lysate mixture was spun 15000 RPM for 20 minutes.

fasciculation and elongation protein 1 (FEZ1), containing poly-

Supernatant was decanted and remaining pellet was let to

glutamate binding regions can directly bind to HIV-1 capsid

resuspend in 20 mL of SA buffer (25 mL HEPES pH 6.8, 0.2

hexamer pores9. Molecules such as polyglutamine binding

mM TCEP) for 4-5 hours. Once pellet was completely

crosslink

individual

hexamers

together,
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resuspended, resuspension was dialyzed in SA buffer at 4oC

Biochemical and structural studies were performed

overnight. The following day, the sample was spun down for 15

using a variety of CA assemblies4: 1) insoluble helical CA tubes,

minutes at 15000 rpm and purified using HiTrap SP (GE) ion

2) soluble hexamers, created from six CA monomers linked

exchange chromatography5. Pentamers preps were identical

together via disulfide bonds, and 3) soluble pentamers, created

except using a HiTrap Q (GE) column. Purified constructs were

from five CA monomers linked together via disulfide bonds.

finished with gel filtration (S200 PG; GE) to ensure protein was

Helical CA tubes, made with cysteine mutations at residues 14

monodisperse. Protein molecular weight and behavior was

and 45, mimic the inter-hexamer interfaces on the native capsid.

analyzed using reducing and non-reducing samples on SDS-

After

PAGE.

(14C|45C|WM)were used in pelleting assays to test molecular

Soluble CA Assembly

binding with selective small molecules. Hexamers were created

assembly,

helical

CA

tubes

labeled

CA

After obtaining uniformly-dispersed CA monomers,

using CA mutant residues at A14C and E45C that were

CA proteins are transferred into a dialyzer cassette and dialyzed

engineered previously in Xiong lab and assembled 5 (Figure 1).

into 50 mM Tris pH 8, 1M NaCl, and 40 mM BME overnight in

The 14C residue of CA forms a disulfide bond with the 45C

4oC cold room. The following day, cassette was transferred to

residue of a neighboring CA to provide stability to hexamers in

dialyze in 50 mM Tris, 1M NaCl for two whole days. Finally,

vitro. Utilizing alanine mutations prevents the inter-hexamer

cassette dialyzed in 50 mM Tris for a day. Following the four-

polymerization as seen in the 14C|45C|WM mutant. Hexamer

day assembly process, soluble CA hexamers and pentamers

mutant constructs were purified and labeled Hexamer

became stably cross-linked and ready for analysis (Figure 1).

14C|45C|AA (Hex AA). These hexamers were soluble allowing
for crystal trays to be set up to characterize their structural
interactions with other molecules. Similarly, pentamers were
created through cysteine mutations at residues 21 and 22 of CA
with residues 21C and 22C of CA forming a disulfide bond to
provide stability to pentamers in vitro. Pentamer mutant
constructs were purified and labeled Pentamer 21C|22C|AA
(Pent AA).
Pelleting assay protocol established in Xiong Lab6 was
used to biochemically assess binding interactions between CA

5

Figure 1. Xiong Lab protocol of in vitro engineered capsid
hexamer design, assembly, and validation. (A.) HIV-1 capsid
hexamers were recreated in vitro via disulfide linkages at residues
14 and 45 of CA (A14C/E45C)5. Using reducing and non-reducing
conditions, hexamers were seen to be composed of monomeric CA
protein. Through established capsid protocols, whole hexamers
were created and purified using CA. Hexamer complexes were run
under reducing and non-reducing gel conditions to reveal dimer,
trimer, and hexamer species as designed. (B.) Assembly products
were run on size exclusion chromatography and were well-behaved
and shown to be monodispersed. Figures obtained from Summer,
B ad /X
, Y
a : Modular HIV-1 Capsid Assemblies
Reveal Diverse Host-Ca d R c
M c a
.

tubes and small molecules of interest. The R18 residue of HIV1 CA A14C/E45C is a target of interest due to that residue being
located at the pore, potentially serving as a binding interactor to
PQBP1 because of glutamate stretches as shown similarly to
FEZ1
capsid9.

b d

ac

c

d c

ral pore of

Pelleting assay takes advantage of the inherent

insolubility of the tubes. Pelleting assay was conducted using
CA tubes incubated with PQBP1, a host protein that directly
interacts with HIV-1 reverse-transcribed DNA and is a crucial
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RESULTS

maltose-binding protein (MBP) as a negative control, CA tubes
and mutant CA tubes were incubated with PQBP1. The mutant

Construct Validation

CA tubes were at the R18D residue removing the positively

Following established purification and assembly

charged residue of CA to determine if binding affinity to PQBP1

protocols, in vitro native capsid hexamers and pentamers were

was affected. Five reactions were created containing the

successfully produced. The CA monomer has a molecular

following proteins: 1) MBP, 2) PQBP1, 3) MBP and CA tubes,

weight of 25 kDa and when in its assembled hexamer

4) PQBP1 and CA tubes, 5) PQBP1 and CA R18D tubes. Gel

configuration, the molecular weight expected is 150 kDa. Non-

samples were taken from the total incubated sample, the post-

reducing and reducing gel samples of Hex AA indicated that the

centrifugation soluble sample, and from the resuspended

species was indeed in the right assembled form with a non-

insoluble pellet of CA tubes.

reducing band at 150 kDa and reducing at 25 kDa, indicating

Purified Hex AA and Pent AA protein were used for

that all disulfide crosslinks were reduced to form component

setting up microbatch under oil crystallization screens with

monomers. Hex AA species also showed high purity via SDS-

various binding partners and small molecules. Hex AA was

PAGE (Figure 2). Pent AA constructs were validated through

incubated with CypA, llama nanobody, and IP6. Pent AA

the same process.

crystallization trays were set up in three different forms: 1) Pent
AA in Apo-form (Pent AA Apo) at 37.5 uM, 2) Pent AA with
CypA at 75 uM, and 3) Pent AA with IP6 at 37.5 uM. Protein
solutions were made with proteins of interest and gel filtration
buffer (50 mM Tris pH8 and 75 mM NaCl). Crystallization was
tested with premade matrix screens including various salt,
buffer, and precipitating agents of polyethylene glycol (PEG).
The following matrix screens used were NeXtal Classics,
Classics Lite, JCSG+, ProComp, and PACT. Crystal trays were
initially set up under standard laboratory protocols4, 5, 6 using a
paraffin:silicon oil ratio of 2:1 and a protein:condition solution
ratio of 1 µL:1 µL. After obtaining initial crystallization hits,
matrix screens were optimized through varying concentrations
of protein:condition ratios followed by pH screen optimization

Figure 2. Hexamer AA Purification Validation. (A.) Non-reducing
and reducing samples of Hex AA from GF were run on SDS-PAGE
to identify the molecular weight of the species. (B.) Post-assembly
and purification, Hex AA was run on size-exclusion
chromatography/gel filtration column (GF) and showed a uniform,
monodispersed peak at the expected retention volume.

and optimization of precipitating agent. Initial crystallization
hits were serially seeded into optimized conditions. Protein

Biochemical Assay

content verified using light microscopy/birefringent lens,

Soluble proteins such as MBP and PQBP1 were expected to

absorption of Coomassie Brilliant Blue dye, ultraviolet

have higher band density in the soluble gel sample and lesser

fluorescence microscopy, and x-ray crystallography.

band density in the pellet gel sample if no significant binding
with CA tubes were present. Total, soluble, and pellet fractions
were analyzed using SDS-PAGE. Pellet samples show

YURJ | yurj.yale.edu
https://elischolar.library.yale.edu/yurj/vol1/iss1/44

4
4

Mao and Temple: Investigating factors that affect HIV-1 capsid stability

STEM
Molecular, Cellular, and Developmental Biology
Social|Sciences

VOL. 1.1 | Dec. 2020

relatively equal amounts of CA tubes loaded along with equal

crystal lattice structure and created more ordered protein

inputs of MBP and PQBP1 (Figure 3). Negative control of MBP

crystals under the same ProComp conditions (Figure 4). Higher

was used as a loading control and was known to have no binding

resolution crystals from the optimization screen were looped out

interactions to CA WM/CA R18D. The R18D residue is of

and sent for x-ray crystallographic data collection. Crystals were

interest due to its location in the central pore of capsid. Soluble

cryoprotected with 25% ethylene glycol solutions before frozen

gel sample appears to show as much PQBP1 protein in

in liquid nitrogen. Diffraction data was collected at NE-CAT

supernatant as when PQBP1 was incubated with CA R18D

beamline 24ID-C at the Advanced Photon Source. Diffraction

tubes, indicating loss of binding for PQBP1 with the CA R18D

data collected at a resolution of ~7Å was not at a high enough

tubes. Pellet gel sample shows CA tubes have highest binding

resolution to observe interactions of interest (Figure 4).

affinity to PQBP1, followed by a faint band density for CA

Crystallization hit from Hex AA with poly-E peptide diffracted

R18D tubes. This experiment showed that PQBP1 had a

at a high-resolution of ~3.5Å (Figure 5).

substantial reduction in its binding affinity to CA tubes when
the R18D mutation was made (Figure 3).

Figure 3. Pelleting assay of CA (WM) tubes/CA R18D tubes with
MBP/PQBP1. Total sample (Input) refers to samples taken from
the pelleting tubes post-incubation of proteins. Soluble sample
(Sup) refers to samples taken of the supernatant from the pelleting
tubes post-centrifugation at 14,500 rpm for 15 minutes at 4oC.
Pellet sample refers to samples taken from the pelleting tubes after
removing supernatant, leaving the insoluble CA tubes with
potentially bound proteins. Total, soluble, and pellet fractions were
analyzed using SDS-PAGE. Figure created via Microsoft
PowerPoint.

Figure 4. Crystallization using microbatch under oil in ProComp
conditions (0.2M Sodium Acetate, 0.1M Sodium Citrate pH 5.5,
10% Polyethylene Glycol 4000) for Hex AA, IP6, llama nanobody,
and CypA. Initial screen refers to standard ProComp conditions
with a ratio of 1:1 for CypA and nanobody. Optimization screen
refers to varying stoichiometric protein ratios between 1x-12x for
CypA and nanobody concentrations while keeping ProComp
conditions same. Crystals observed under light microscopy and
photographed. Pictures formatted on Microsoft PowerPoint.

Hexamer Crystals
Crystallization hits were obtained from varying matrix
screens of ProComp, PACT, and JCSG+. Initial crystal hit of
Hex AA with CypA, llama nanobody, and IP6 in ProComp
(0.2M Sodium Acetate, 0.1M Sodium Citrate pH 5.5, 10%
Polyethylene Glycol 4000) was optimized through varying
stoichiometric protein concentration ratios4 (ranging from 1x to
12x) between CypA and Llama nanobody which improved

Figure 5. Crystallization using microbatch under oil for Hex AA
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and poly-E peptide. Crystals observed under light microscopy and
photographed. Pictures formatted on Microsoft PowerPoint.

Pent AA with CypA

Pentamer Crystals

Sodium Iodide, 0.1M Bis Tris Propane pH 7.5, and 20%

Initial crystallization hits were in PACT screens (0.2M

Crystallization hits were obtained from varying matrix

Polyethylene Glycol 3350; 0.2M Sodium Iodide, 0.1M Bis Tris

screens of JCSG+, PACT, and ProComp. Initial crystal hits in

propane pH 8.5, and 20% Polyethylene Glycol 3350) and

PACT, JCSG+, and ProComp were serially seeded into the same

ProComp (0.1M MES pH 6.5 and 15% Polyethylene Glycol 550

conditions and observed. JCSG+ screens failed to reproduce

MME; 0.1M Magnesium Chloride, 0.1M HEPES pH 7.5, and

crystals and were not pursued for further analysis with Pent AA.

10% Polyethylene Glycol 4000). Initial hits were serially seeded
into

Pent AA (APO)

crystal

condition

hits.

Post-serial

seeding,

ratio

optimizations of protein:condition solution ranging from 0.25x

Post-serial

seeding,

of

to 3x were performed in matrix screen hits of PACT and

protein:condition solution ranging from 0.25x to 3x were

ProComp. PACT failed to reproduce initial crystallization hits

performed in matrix screen hits of ProComp (0.1M Magnesium

with Pent AA CypA. ProComp condition 0.1M HEPES pH 7.5,

Chloride, 0.1M HEPES pH7, and 15% Polyethylene Glycol

and 10% Polyethylene Glycol 4000 produced the most uniform,

4000; 0.2M Ammonium Sulfate, 0.1M MES pH 6.5, and 20%

singular crystals post-ratio optimization. Pent AA with CypA

Polyethylene

hits generally precipitated crystals within 30 days of setting up

Glycol

8000)

ratio

and

optimizations

PACT

(0.2M

Sodium/Potassium Phosphate and 20% Polyethylene Glycol

crystallization trays.

3350) (Figure 6). PACT solutions produced jagged, nonuniform and heterogeneous crystals. ProComp condition (0.2M

Pent AA with IP6

Ammonium Sulfate 0.1M MES pH 6.5, and 20% Polyethylene

Initial crystallization hits were in ProComp screen

Glycol 8000) produced the most uniform crystals out of the Pent

(0.1M Sodium Citrate pH 5 and 8% Polyethylene Glycol 8000)

AA Apo hits. Pent AA Apo hits generally precipitated crystals

and PACT screens (0.2M Sodium Chloride, 0.1M MES pH 6,

within 6 days of setting up crystallization trays (Figure 6).

and 20% Polyethylene Glycol 6000; 0.2M Magnesium
Chloride, 0.1M HEPES pH 7, and 20% Polyethylene Glycol
6000) (Figure 7). Initial hits were serially seeded into crystal
condition hits. Post-serial seeding, ratio optimizations of
protein:condition solution ranging from 0.25x to 3x were
performed in matrix screen hits of PACT and ProComp.
Optimized crystal hits from PACT 0.2M Magnesium Chloride,
0.1M HEPES pH 7, and 20% Polyethylene Glycol 6000
produced the most uniform and singular crystals. Ratio
optimization was followed by HEPES pH gradient from 6.0 to

Figure 6. Pent AA (Apo) crystallization using microbatch under oil
in ProComp conditions (0.2M Sodium Acetate, 0.1M MES pH 6.5,
20% Polyethylene Glycol 8000). (A.) Left image shows bottom of
microbatch under oil drop. (B.) Right image shows surfa view ce
of same drop. Crystals observed under light microscopy and
photographed. Pictures formatted on Microsoft PowerPoint.
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followed by a 30% PEG screen (ranging PEG 400 to PEG

small molecules of interest to characterize the capsid lattice

20000) with protein:condition solution ratios of (1:1, 1:1.5, and

structure.

1:2). Pent AA with IP6 hits generally precipitated crystals
within 7 days of setting up crystallization trays (Figure 7).

Given that each capsid fullerene cone contains ~200
hexamers, studying the hexamer structure presents opportunities
to identify small molecule factors that may stabilize its presence
in host organisms. IP6 is an essential HIV pocket factor that
prevents capsid collapse with the six negatively charged
phosphate groups stabilizing the positively charged arginine
ring of hexamers2. Hex AA with IP6, CypA, and llama
nanobody crystal hits from initial ProComp matrix screen (0.2M
Sodium Acetate, 0.1M Sodium Citrate pH 5.5, 10%
Polyethylene Glycol 4000) were successfully optimized as

Figure 7. Pent AA with IP6 crystallization using microbatch under
oil. (A.) Initial crystal hit for ProComp conditions (0.2M
Magnesium Chloride, 0.1M HEPES pH7, and 20% Polyethylene
Glycol 6000) observed on 01-22-20. (B.) Crystal hit postprotein:condition ratio/pH/precipitating agent optimization with
conditions: 0.2M Magnesium Chloride, 0.1M HEPES pH 7.4, and
30% Polyethylene Glycol 6000 observed on 02-07-20. Crystals
observed under light microscopy and photographed. Pictures
formatted on Microsoft PowerPoint.

shown by the growth in size and density (Figure 4). Due to a
variety of external factors, including crystal lattice order,
molecular

packing

and

beam

intensity

from

x-ray

crystallography, the diffraction data collected at NE-CAT
beamline 24ID-C at the Advanced Photon Source was not high
resolution. Lack of resolution could be attributed to CypA and
llama nanobody creating too dynamic of a lattice to have solid
packing and good order for data collection. Poly-E peptide was

DISCUSSION

examined as a potential binding candidate to Hex AA due to
having similar glutamate stretches as FEZ19 and PQBP1. High-

Analysis of key binding regions in CA tubes provides

resolution diffraction data of Hex AA with poly-E peptide was

novel information on capsid structure and stability. Molecules

obtained at 3.5 Å (Figure 5). Data is currently being processed

containing poly-glutamate stretches have been shown to interact

for structural analysis. Poly-E peptide has a chain of glutamates

with the centrally-charged pore region of capsid such as FEZ19.

that was thought to have high binding affinity to the central

This indicates a key binding region for small stabilizing

capsid pore. Our crystallization results indicated that poly-E

molecules. As expected, when the CA tubes were mutated with

peptide did indeed bind to the charged hexamer pore. This

R18D, there was a loss of binding to PQBP1, a molecule

discovery aligns with prior studies where hexamer pore was

containing similar glutamate stretches (Figure 3). Results

shown to bind to poly-glutamate stretches9. Further studies

indicate that we now know PQBP1 specifically targets the CA

include setting repeats of with Hex AA in its most optimized

hexamer pore. Pelleting assays6 are currently in progress using

state with variations in pH, temperature, protein concentrations,

mutant residues of PQBP1 to test which regions of PQBP1

and molecules present as all of these factors can play a role in

interact with CA hexamer pore (Figure 3). Further pelleting

the stability and crystal lattice formation. Small molecules of

assays will be conducted with restriction factors of interest and

interest including, but not limited to: IP6, various dNTPs, CypA,
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llama nanobody, and other phosphate moieties in combination

IP6 crystals came from PACT condition (0.2M MgCl2, 0.1M

with other matrix screens can be set up.

HEPES pH 7.4, and 30% PEG 6000). Interestingly, when Pent

Each capsid fullerene cone contains 12 pentamers that

AA was present with either CypA or IP6, it preferred conditions

have points of the highest stress due to being essential for the

of magnesium chloride (0.1-0.2M MgCl2) and HEPES (pH 7.4-

curvature of the cone. Due to this increased stress, regions in the

7.5). The solution conditions between Pent AA CypA and Pent

pentamer could be where capsid initially breaks open to release

AA IP6 were in fact almost identical. Surprisingly, Pent AA

its viral genome into the host. and thus presents an interesting

with CypA took the longest time to produce crystals (~30 days)

target to study. U

compared to Pent AA Apo or Pent AA IP6 (~6 days). Given that

a

,

a

d

a

a

symmetry problem since lattices do not allow 5-fold symmetry

the crystallization trays tested were almost identical aside from

to propagate. Currently, there are no structures of pentamers

the small molecules of interest, I expected the Pent AA crystals

with small molecules and presents an interesting target for

to all precipitate at relatively similar time periods. Being that

analysis. First, crystallization trays of the Apo-form of Pent AA

microbatch under oil crystallization techniques allow for the

were set up in order to understand baseline conditions that affect

slow evaporation of condition under oil, it is not unreasonable

the stability and structure of them in solution (Figure 6). After

that crystals can be formed at later time periods due to varying

setting up various matrix screens, it appeared that Pent AA was

evaporation rates that alter protein concentrations present.

generally most stable in pH ranges between 6-7 with higher

Unfortunately, due to the COVID-19 pandemic, novel

molecular weight precipitating agents (PEG 6000-8000) at a 20-

optimized Pent AA crystals, observed in late February, in Apo-

30% ratio. After months of trial and error with optimization, it

form, with IP6, and CypA could not be shot and analyzed using

is noteworthy that the crystals produced from Pent AA Apo

beam time. Future directions include the continued optimization

generally remained the same size even after optimization of

of Hex AA and Pent AA crystals with higher resolution crystals

matrix screens, protein:condition solution, pH, and precipitating

analyzed using x-ray crystallography. Furthermore, in vitro

agent. The lack of crystal growth and density could be attributed

fullerene capsid shells could be created and tested to understand

to the lack of molecules present in solution and/or the pentamer

the macromolecular stability of capsid. By obtaining diffraction

structure inhibiting higher ordered lattice packing. CypA with

patterns of capsid crystals, an electron density map and model

llama nanobody could be used as cofactors to break the six-fold

of the molecular interactions can be created. By continuing to

symmetry when bound to Hex

AA4,5.

CypA was a host factor

optimize crystals to achieve better resolutions, more precise

that when combined to llama nanobody and Hex AA allowed

models of the molecular interactions can be obtained.

for symmetry breaking and the visualization of molecular

U

interactions in capsid hexamers. Pent AA with CypA presented

metastable condition and further understand how its domains

a novel opportunity to characterize a potential interaction

are affected spatial and temporal for novel drug targeting.

a

,

d

ca b

d

c a ac

ca

d

between them. After months of optimization from matrix
screens, the most ordered crystals produced came from

ENDNOTES

ProComp condition (0.1M MgCl2, 0.1M HEPES pH 7.5, and
10% PEG 4000). Given that IP6 was a stabilizing molecule for

1

Hex AA, Pent AA incubated with IP6 presented an interesting

Disease Control and Prevention, Centers for Disease Control and

novel target to study (Figure 7). The most ordered Pent AA with

Prevention, 14 Aug. 2019.

YURJ | yurj.yale.edu
https://elischolar.library.yale.edu/yurj/vol1/iss1/44

Ab

HIV/AIDS HIV Ba c

HIV/AIDS CDC. Centers for

8
8

Mao and Temple: Investigating factors that affect HIV-1 capsid stability

STEM
Molecular, Cellular, and Developmental Biology
Social|Sciences

VOL. 1.1 | Dec. 2020

2

Ma
,D
a L, a . F
a d Da a IP6 I an HIV Pocket
Factor That Prevents Capsid Collapse and Promotes DNA
S
. ELifeSciences.org, Life Sciences Publications Limited,
31 May 2018.
3

Jac
, Da d A, a . HIV-1 Uses Dynamic Capsid Pores to
Import
Nucleotides
and
Fuel
Encapsidated
DNA
S
. Nature.com, Macmillan Publishers Limited, 10 Aug.
2016.
4

G b , E a E, a . CA-targeting nanobody is a tool for studying
HIV-1 ca d a c
ac
. Xiong Laboratory. 13 July 2019.
Unpublished.
5

S
, B ad ,
a . Modular HIV-1 Capsid Assemblies
Reveal Diverse Host-Ca d R c
M c a
. Cell Host
& Microbe, 203 216. August 14, 2019. Published by Elsevier Ltd.
6

S a a, Sa a S, a . MxB Restricts HIV-1 by Targeting the Trihexamer interface of the Viral Ca d. Cell Press, 1234-1245.
August 6, 2019. Published by Elsevier Ltd.
7

Yoh, Sunnie M. PQBP1 Is a Proximal Sensor of the CGASDependent Innate Response to HIV-1. Cell/CellPress , 4 June 2015.
Published by Elsevier Ltd.
8

G a , E. R.,
a HIV d a

a . A a d ca
a
. AIDS 32, 2089-2102. 2018.

9

d

Huang, Pei-T .,
a . FEZ1 I R c
d
a C
Cofactor
Site
on
Capsid
to
Promote
Ta c
. Www.cell.com, Cell Reports, 27 Aug. 2019.

c
d
HIV-1

YURJ | yurj.yale.edu
Published by EliScholar – A Digital Platform for Scholarly Publishing at Yale, 2020

9
9

